The Brookline Team

Dedicated Professionals


Equity Research

Dr. Raja has significant experience as an Equity Analyst in the healthcare industry with a focus on the biotechnology sector. Previously, he was Vice President, Biotechnology Research at Noble Life Science Partners. He started his equity research career in 2010 as a Senior Associate Analyst on the Citi Research biotechnology team that was continuously ranked highly for biotechnology in the Institutional Investor All-America survey.


Dr. Raja’s expertise includes bottom-up scientific and financial analysis on companies across therapeutic areas and across a spectrum of market capitalizations. He has a strong quantitative and scientific background with in-depth biotechnology and healthcare industry knowledge leveraged to identify compelling investment opportunities. Dr. Raja has substantial experience working with leading U.S. institutional clients. He has deep knowledge of the healthcare industry including drug development, intellectual property, FDA and EMA regulations, reimbursement coverage and clinical science. He conducted post-doctoral research at Mayo Clinic to understand the epigenetic causes of cancer and at Los Angeles Biomedical Research Institute to elucidate the molecular mechanisms concerning the role of human bone marrow stem cells in normal and leukemic hematopoiesis.


Dr. Raja received his Doctor of Philosophy degree from Bowling Green State University and MBA from University of California, San Diego.

Ms. Yanchus has significant experience as a healthcare analyst on both the buy and the sell sides.  She was most recently the global healthcare analyst at Tradewinds Global Investments, a division of Nuveen.  Prior to that she was a pharmaceutical and biotech analyst at Bessemer Investments and a biotech analyst at The Galleon Group. Ms. Yanchus covered life sciences stocks on the sell side at Oppenheimer & Co., Lehman Brothers, and Morgan Stanley.  

She graduated magna cum laude and Phi Betta Kappa from Wellesley College with a B.A. in Economics, and received her MBA in Finance from Columbia University’s School of Business. 

Investment Banking



Senior Advisors